Episode 11 of “Pipettes and Politics” is available
In the latest episode of the ASBMB science policy podcast, public affairs staff members provide updates on the fiscal year 2019 Labor Health and Human Services appropriations. Staff members also discuss the society’s August is for Advocacy annual campaign and recap the society’s response to the National Institute of General Medical Sciences’ request for input on how to increase faculty diversity. Mary Woolley, president and chief executive officer for Research!America, joins the podcast to discuss the importance of science advocacy and how to get involved. Listen to this episode on Soundcloud, iTunes or Stitcher.
Advocate for science by signing up for ASBMB’s August is for Advocacy campaign
The ASBMB encourages you to participate in its annual summer campaign advocating for the scientific enterprise. Society staff will help you set up meetings with your congressional representatives at their hometown headquarters, send you materials you can use during your visit, and prepare you for your discussions with lawmakers. Learn more by joining ASBMB’s webinar at 1:30 p.m. Eastern on Wednesday, July 25. Sign up to join the summer advocacy campaign here.
Study shows women maintain NIH funding at rates similar to men
A recent study has shown that men and women maintain funding from the National Institutes of Health at similar rates. Co-author Judith Greenberg said she hopes that these findings will change the narrative that women will not succeed in science. Read more here.
Funding for research could top $85 billion for FY19
Spending bills passed by the U.S. Senate appropriations committees could surpass a record $85 billion for research funding in fiscal year 2019. The NIH, the National Science Foundation, and the Department of Energy Office of Science would all see increases of at least 2.9 percent. However, no spending bills have yet passed the full House or Senate. Read more here.
Several findings suggest DNA editing by CRISPR has off-target effects
Several groups have published data showing that cells that have undergone DNA editing with CRISPR exhibit unwanted genetic changes. These findings further complicate discussions surrounding the safety of using CRISPR in humans. Read more here.